药物对比
Saxagliptin vs Rosiglitazone
比较Saxagliptin（Onglyza）与Rosiglitazone治疗2型糖尿病。回顾作用机制、疗效、副作用、心血管风险、体重影响和患者适用性。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered for type 2 diabetes patients needing an alternative oral agent due to inadequate A1C control, weight concerns, or cardiovascular comorbidities.
结论
Saxagliptin is generally preferred over rosiglitazone due to lower heart failure and fluid retention risks, though neither is ideal for all patients.
全部药物对比